Talaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ tran…

Biotechnology
US, Louisville [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of TALS's Analysis
CIK: - CUSIP: 87410C104 LEI: - UEI: -
Secondary Listings
TALS has no secondary listings inside our databases.